{
  "DOI": "10.1186/s40246-021-00372-x",
  "ISSN": [
    "1479-7364"
  ],
  "URL": "http://dx.doi.org/10.1186/s40246-021-00372-x",
  "abstract": "\u003cjats:title\u003eAbstract\u003c/jats:title\u003e\u003cjats:sec\u003e\n                \u003cjats:title\u003eBackground\u003c/jats:title\u003e\n                \u003cjats:p\u003eThe unfolded protein response (UPR) served as a vital role in the progression of tumors, but the molecule mechanisms of UPR in bladder cancer (BLCA) have been not fully investigated.\u003c/jats:p\u003e\n              \u003c/jats:sec\u003e\u003cjats:sec\u003e\n                \u003cjats:title\u003eMethods\u003c/jats:title\u003e\n                \u003cjats:p\u003eWe identified differentially expressed unfolded protein response-related genes (UPRRGs) between BLCA samples and normal bladder samples in the Cancer Genome Atlas (TCGA) database. Univariate Cox analysis and the least absolute shrinkage and selection operator penalized Cox regression analysis were used to construct a prognostic signature in the TCGA set. We implemented the validation of the prognostic signature in GSE13507 from the Gene Expression Omnibus database. The ESTIMATE, CIBERSORT, and ssGSEA algorithms were used to explore the correlation between the prognostic signature and immune cells infiltration as well as key immune checkpoints (PD-1, PD-L1, CTLA-4, and HAVCR2). GDSC database analyses were conducted to investigate the chemotherapy sensitivity among different groups. GSEA analysis was used to explore the potential mechanisms of UPR-based signature.\u003c/jats:p\u003e\n              \u003c/jats:sec\u003e\u003cjats:sec\u003e\n                \u003cjats:title\u003eResults\u003c/jats:title\u003e\n                \u003cjats:p\u003eA prognostic signature comprising of seven genes (CALR, CRYAB, DNAJB4, KDELR3, CREB3L3, HSPB6, and FBXO6) was constructed to predict the outcome of BLCA. Based on the UPRRGs signature, the patients with BLCA could be classified into low-risk groups and high-risk groups. Patients with BLCA in the low-risk groups showed the more favorable outcomes than those in the high-risk groups, which was verified in GSE13507 set. This signature could serve as an autocephalous prognostic factor in BLCA. A nomogram based on risk score and clinical characteristics was established to predict the over survival of BLCA patients. Furthermore, the signature was closely related to immune checkpoints (PD-L1, CTLA-4, and HAVCR2) and immune cells infiltration including CD8\u003cjats:sup\u003e+\u003c/jats:sup\u003e T cells, follicular helper T cells, activated dendritic cells, and M2 macrophages. GSEA analysis indicated that immune and carcinogenic pathways were enriched in high-risk group.\u003c/jats:p\u003e\n              \u003c/jats:sec\u003e\u003cjats:sec\u003e\n                \u003cjats:title\u003eConclusions\u003c/jats:title\u003e\n                \u003cjats:p\u003eWe identified a novel unfolded protein response-related gene signature which could predict the over survival, immune microenvironment, and chemotherapy response of patients with bladder cancer.\u003c/jats:p\u003e\n              \u003c/jats:sec\u003e",
  "alternative-id": [
    "372"
  ],
  "article-number": "73",
  "assertion": [
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Received",
      "name": "received",
      "order": 1,
      "value": "8 July 2021"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Accepted",
      "name": "accepted",
      "order": 2,
      "value": "3 December 2021"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "First Online",
      "name": "first_online",
      "order": 3,
      "value": "20 December 2021"
    },
    {
      "group": {
        "label": "Declarations",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 1
    },
    {
      "group": {
        "label": "Ethics approval and consent to participate.",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 2,
      "value": "Not applicable."
    },
    {
      "group": {
        "label": "Consent for publication",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 3,
      "value": "Not applicable."
    },
    {
      "group": {
        "label": "Competing interests",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 4,
      "value": "The authors declare that they have no competing interests."
    }
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Zhu",
      "given": "Ke",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Xiaoqiang",
      "given": "Liu",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Deng",
      "given": "Wen",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Wang",
      "given": "Gongxian",
      "sequence": "additional"
    },
    {
      "ORCID": "http://orcid.org/0000-0001-6686-7561",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "Fu",
      "given": "Bin",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "Human Genomics"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": [
      "link.springer.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2021,
        12,
        20
      ]
    ],
    "date-time": "2021-12-20T10:03:12Z",
    "timestamp": 1639994592000
  },
  "deposited": {
    "date-parts": [
      [
        2022,
        10,
        26
      ]
    ],
    "date-time": "2022-10-26T04:05:52Z",
    "timestamp": 1666757152000
  },
  "funder": [
    {
      "DOI": "10.13039/501100001809",
      "award": [
        "81960512"
      ],
      "doi-asserted-by": "publisher",
      "name": "national natural science foundation of china"
    }
  ],
  "indexed": {
    "date-parts": [
      [
        2024,
        3,
        1
      ]
    ],
    "date-time": "2024-03-01T19:45:48Z",
    "timestamp": 1709322348438
  },
  "is-referenced-by-count": 8,
  "issn-type": [
    {
      "type": "electronic",
      "value": "1479-7364"
    }
  ],
  "issue": "1",
  "issued": {
    "date-parts": [
      [
        2021,
        12,
        20
      ]
    ]
  },
  "journal-issue": {
    "issue": "1",
    "published-online": {
      "date-parts": [
        [
          2021,
          12
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "https://creativecommons.org/licenses/by/4.0",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2021,
            12,
            20
          ]
        ],
        "date-time": "2021-12-20T00:00:00Z",
        "timestamp": 1639958400000
      }
    },
    {
      "URL": "https://creativecommons.org/licenses/by/4.0",
      "content-version": "vor",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2021,
            12,
            20
          ]
        ],
        "date-time": "2021-12-20T00:00:00Z",
        "timestamp": 1639958400000
      }
    }
  ],
  "link": [
    {
      "URL": "https://link.springer.com/content/pdf/10.1186/s40246-021-00372-x.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://link.springer.com/article/10.1186/s40246-021-00372-x/fulltext.html",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://link.springer.com/content/pdf/10.1186/s40246-021-00372-x.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "prefix": "10.1186",
  "published": {
    "date-parts": [
      [
        2021,
        12,
        20
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2021,
        12,
        20
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1016/S0140-6736(16)30512-8",
      "author": "AM Kamat",
      "doi-asserted-by": "publisher",
      "first-page": "2796",
      "issue": "10061",
      "journal-title": "The Lancet",
      "key": "372_CR1",
      "unstructured": "Kamat AM, Hahn NM, Efstathiou JA, Lerner SP, Malmström P-U, Choi W, et al. Bladder cancer. The Lancet. 2016;388(10061):2796–810.",
      "volume": "388",
      "year": "2016"
    },
    {
      "DOI": "10.3322/caac.21631",
      "author": "VG Patel",
      "doi-asserted-by": "publisher",
      "first-page": "404",
      "issue": "5",
      "journal-title": "CA Cancer J Clin",
      "key": "372_CR2",
      "unstructured": "Patel VG, Oh WK, Galsky MD. Treatment of muscle-invasive and advanced bladder cancer in 2020. CA Cancer J Clin. 2020;70(5):404–23.",
      "volume": "70",
      "year": "2020"
    },
    {
      "DOI": "10.1016/S0962-8924(98)01267-7",
      "author": "C Sidrauski",
      "doi-asserted-by": "publisher",
      "first-page": "245",
      "issue": "6",
      "journal-title": "Trends Cell Biol",
      "key": "372_CR3",
      "unstructured": "Sidrauski C, Chapman R, Walter P. The unfolded protein response: an intracellular signalling pathway with many surprising features. Trends Cell Biol. 1998;8(6):245–9.",
      "volume": "8",
      "year": "1998"
    },
    {
      "DOI": "10.1101/gad.13.10.1211",
      "author": "RJ Kaufman",
      "doi-asserted-by": "publisher",
      "first-page": "1211",
      "issue": "10",
      "journal-title": "Genes Dev",
      "key": "372_CR4",
      "unstructured": "Kaufman RJ. Stress signaling from the lumen of the endoplasmic reticulum: coordination of gene transcriptional and translational controls. Genes Dev. 1999;13(10):1211–33.",
      "volume": "13",
      "year": "1999"
    },
    {
      "DOI": "10.1186/1756-8722-4-8",
      "author": "X Li",
      "doi-asserted-by": "publisher",
      "first-page": "8",
      "issue": "1",
      "journal-title": "J Hematol Oncol",
      "key": "372_CR5",
      "unstructured": "Li X, Zhang K, Li Z. Unfolded protein response in cancer: the Physician’s perspective. J Hematol Oncol. 2011;4(1):8.",
      "volume": "4",
      "year": "2011"
    },
    {
      "DOI": "10.1016/j.cub.2012.07.004",
      "author": "SS Cao",
      "doi-asserted-by": "publisher",
      "first-page": "R622",
      "issue": "16",
      "journal-title": "Curr Biol",
      "key": "372_CR6",
      "unstructured": "Cao SS, Kaufman RJ. Unfolded protein response. Curr Biol. 2012;22(16):R622–6.",
      "volume": "22",
      "year": "2012"
    },
    {
      "author": "G Wang",
      "first-page": "65",
      "issue": "1",
      "journal-title": "Am J Transl Res",
      "key": "372_CR7",
      "unstructured": "Wang G, Yang Z-Q, Zhang K. Endoplasmic reticulum stress response in cancer: molecular mechanism and therapeutic potential. Am J Transl Res. 2010;2(1):65–74.",
      "volume": "2",
      "year": "2010"
    },
    {
      "DOI": "10.1172/JCI0216784",
      "author": "D Ron",
      "doi-asserted-by": "publisher",
      "first-page": "1383",
      "issue": "10",
      "journal-title": "J Clin Invest",
      "key": "372_CR8",
      "unstructured": "Ron D. Translational control in the endoplasmic reticulum stress response. J Clin Invest. 2002;110(10):1383–8.",
      "volume": "110",
      "year": "2002"
    },
    {
      "DOI": "10.1016/S1097-2765(01)00265-9",
      "author": "D Scheuner",
      "doi-asserted-by": "publisher",
      "first-page": "1165",
      "issue": "6",
      "journal-title": "Mol Cell juin",
      "key": "372_CR9",
      "unstructured": "Scheuner D, Song B, McEwen E, Liu C, Laybutt R, Gillespie P, et al. Translational Control Is Required for the Unfolded Protein Response and In Vivo Glucose Homeostasis. Mol Cell juin. 2001;7(6):1165–76.",
      "volume": "7",
      "year": "2001"
    },
    {
      "DOI": "10.1016/S0092-8674(00)80855-7",
      "author": "K Mori",
      "doi-asserted-by": "publisher",
      "first-page": "451",
      "issue": "5",
      "journal-title": "Cell mai",
      "key": "372_CR10",
      "unstructured": "Mori K. Tripartite management of unfolded proteins in the endoplasmic reticulum. Cell mai. 2000;101(5):451–4.",
      "volume": "101",
      "year": "2000"
    },
    {
      "DOI": "10.1038/onc.2010.153",
      "author": "E Bobrovnikova-Marjon",
      "doi-asserted-by": "publisher",
      "first-page": "3881",
      "issue": "27",
      "journal-title": "Oncogene",
      "key": "372_CR11",
      "unstructured": "Bobrovnikova-Marjon E, Grigoriadou C, Pytel D, Zhang F, Ye J, Koumenis C, et al. PERK promotes cancer cell proliferation and tumor growth by limiting oxidative DNA damage. Oncogene. 2010;29(27):3881–95.",
      "volume": "29",
      "year": "2010"
    },
    {
      "DOI": "10.1038/s41419-021-03555-5",
      "author": "C Li",
      "doi-asserted-by": "publisher",
      "first-page": "286",
      "issue": "4",
      "journal-title": "Cell Death Dis avr",
      "key": "372_CR12",
      "unstructured": "Li C, Huang Y, Fan Q, Quan H, Dong Y, Nie M, et al. p97/VCP is highly expressed in the stem-like cells of breast cancer and controls cancer stemness partly through the unfolded protein response. Cell Death Dis avr. 2021;12(4):286.",
      "volume": "12",
      "year": "2021"
    },
    {
      "DOI": "10.1172/JCI44855",
      "author": "MD Siegelin",
      "doi-asserted-by": "publisher",
      "first-page": "1349",
      "issue": "4",
      "journal-title": "J Clin Invest",
      "key": "372_CR13",
      "unstructured": "Siegelin MD, Dohi T, Raskett CM, Orlowski GM, Powers CM, Gilbert CA, et al. Exploiting the mitochondrial unfolded protein response for cancer therapy in mice and human cells. J Clin Invest. 2011;121(4):1349–60.",
      "volume": "121",
      "year": "2011"
    },
    {
      "DOI": "10.1016/j.semcancer.2015.04.002",
      "author": "F Tameire",
      "doi-asserted-by": "publisher",
      "first-page": "3",
      "journal-title": "Semin Cancer Biol",
      "key": "372_CR14",
      "unstructured": "Tameire F, Verginadis II, Koumenis C. Cell intrinsic and extrinsic activators of the unfolded protein response in cancer: mechanisms and targets for therapy. Semin Cancer Biol. 2015;33:3–15.",
      "volume": "33",
      "year": "2015"
    },
    {
      "DOI": "10.1016/j.trecan.2017.07.002",
      "author": "N Rufo",
      "doi-asserted-by": "publisher",
      "first-page": "643",
      "issue": "9",
      "journal-title": "Trends Cancer sept",
      "key": "372_CR15",
      "unstructured": "Rufo N, Garg AD, Agostinis P. The unfolded protein response in immunogenic cell death and cancer immunotherapy. Trends Cancer sept. 2017;3(9):643–58.",
      "volume": "3",
      "year": "2017"
    },
    {
      "DOI": "10.3390/cancers12020333",
      "author": "AM Martelli",
      "doi-asserted-by": "publisher",
      "first-page": "333",
      "issue": "2",
      "journal-title": "Cancers",
      "key": "372_CR16",
      "unstructured": "Martelli AM, Paganelli F, Chiarini F, Evangelisti C, McCubrey JA. The unfolded protein response: a novel therapeutic target in acute leukemias. Cancers. 2020;12(2):333.",
      "volume": "12",
      "year": "2020"
    },
    {
      "DOI": "10.1186/1476-4598-9-3",
      "author": "W-J Kim",
      "doi-asserted-by": "publisher",
      "first-page": "3",
      "journal-title": "Mol Cancer",
      "key": "372_CR17",
      "unstructured": "Kim W-J, Kim E-J, Kim S-K, Kim Y-J, Ha Y-S, Jeong P, et al. Predictive value of progression-related gene classifier in primary non-muscle invasive bladder cancer. Mol Cancer. 2010;9:3.",
      "volume": "9",
      "year": "2010"
    },
    {
      "DOI": "10.1111/cas.14876",
      "author": "H-H Zhang",
      "doi-asserted-by": "publisher",
      "first-page": "2199",
      "issue": "6",
      "journal-title": "Cancer Sci",
      "key": "372_CR18",
      "unstructured": "Zhang H-H, Li C, Ren J-W, Liu L, Du X-H, Gao J, et al. OTUB1 facilitates bladder cancer progression by stabilizing ATF6 in response to endoplasmic reticulum stress. Cancer Sci. 2021;112(6):2199–209.",
      "volume": "112",
      "year": "2021"
    },
    {
      "DOI": "10.3389/fcell.2021.641836",
      "author": "Y-Q Hua",
      "doi-asserted-by": "publisher",
      "first-page": "641836",
      "journal-title": "Front Cell Dev Biol",
      "key": "372_CR19",
      "unstructured": "Hua Y-Q, Zhang K, Sheng J, Ning Z-Y, Li Y, Shi W, et al. NUCB1 suppresses growth and shows additive effects with gemcitabine in pancreatic ductal adenocarcinoma via the unfolded protein response. Front Cell Dev Biol. 2021;9:641836.",
      "volume": "9",
      "year": "2021"
    },
    {
      "DOI": "10.1111/boc.201800050",
      "author": "E Madden",
      "doi-asserted-by": "publisher",
      "first-page": "1",
      "issue": "1",
      "journal-title": "Biol Cell",
      "key": "372_CR20",
      "unstructured": "Madden E, Logue SE, Healy SJ, Manie S, Samali A. The role of the unfolded protein response in cancer progression: from oncogenesis to chemoresistance. Biol Cell. 2019;111(1):1–17.",
      "volume": "111",
      "year": "2019"
    },
    {
      "DOI": "10.7717/peerj.10462",
      "author": "W Qi",
      "doi-asserted-by": "publisher",
      "first-page": "e10462",
      "journal-title": "PeerJ",
      "key": "372_CR21",
      "unstructured": "Qi W, Zhang Q. Development and clinical validation of a 3-miRNA signature to predict prognosis of gastric cancer. PeerJ. 2021;9:e10462.",
      "volume": "9",
      "year": "2021"
    },
    {
      "DOI": "10.3389/fgene.2020.00992",
      "author": "Y Wu",
      "doi-asserted-by": "publisher",
      "first-page": "992",
      "journal-title": "Front Genet",
      "key": "372_CR22",
      "unstructured": "Wu Y, Liu Y, He A, Guan B, He S, Zhang C, et al. Identification of the Six-RNA-binding protein signature for prognosis prediction in bladder cancer. Front Genet. 2020;11:992.",
      "volume": "11",
      "year": "2020"
    },
    {
      "DOI": "10.1002/jcb.27847",
      "author": "L Zhang",
      "doi-asserted-by": "publisher",
      "first-page": "5636",
      "issue": "4",
      "journal-title": "J Cell Biochem",
      "key": "372_CR23",
      "unstructured": "Zhang L, Chen S, Wang B, Su Y, Li S, Liu G, et al. An eight-long noncoding RNA expression signature for colorectal cancer patients’ prognosis. J Cell Biochem. 2019;120(4):5636–43.",
      "volume": "120",
      "year": "2019"
    },
    {
      "DOI": "10.3233/CBM-191017",
      "author": "Y Gu",
      "doi-asserted-by": "publisher",
      "first-page": "265",
      "issue": "2",
      "journal-title": "Cancer Biomark",
      "key": "372_CR24",
      "unstructured": "Gu Y, Chen G, Lin P, Cheng J, Huang Z, Luo J, et al. Development and validation of an immune prognostic classifier for clear cell renal cell carcinoma. Cancer Biomark. 2020;27(2):265–75.",
      "volume": "27",
      "year": "2020"
    },
    {
      "DOI": "10.1155/2015/526524",
      "author": "Y-C Lu",
      "doi-asserted-by": "publisher",
      "first-page": "526524",
      "journal-title": "BioMed Res Int",
      "key": "372_CR25",
      "unstructured": "Lu Y-C, Weng W-C, Lee H. Functional roles of calreticulin in cancer biology. BioMed Res Int. 2015;2015:526524.",
      "volume": "2015",
      "year": "2015"
    },
    {
      "DOI": "10.1097/MPA.0000000000001772",
      "author": "Y Fujiwara",
      "doi-asserted-by": "publisher",
      "first-page": "405",
      "issue": "3",
      "journal-title": "Pancreas",
      "key": "372_CR26",
      "unstructured": "Fujiwara Y, Tsunedomi R, Yoshimura K, Matsukuma S, Fujiwara N, Nishiyama M, et al. Pancreatic cancer stem-like cells with high calreticulin expression associated with immune surveillance. Pancreas. 2021;50(3):405–13.",
      "volume": "50",
      "year": "2021"
    },
    {
      "DOI": "10.1038/s41422-020-0383-9",
      "author": "J Fucikova",
      "doi-asserted-by": "publisher",
      "first-page": "5",
      "issue": "1",
      "journal-title": "Cell Res",
      "key": "372_CR27",
      "unstructured": "Fucikova J, Spisek R, Kroemer G, Galluzzi L. Calreticulin and cancer. Cell Res. 2021;31(1):5–16.",
      "volume": "31",
      "year": "2021"
    },
    {
      "DOI": "10.1186/s40425-019-0781-z",
      "author": "L Kasikova",
      "doi-asserted-by": "publisher",
      "first-page": "312",
      "journal-title": "J Immunother Cancer",
      "key": "372_CR28",
      "unstructured": "Kasikova L, Hensler M, Truxova I, Skapa P, Laco J, Belicova L, et al. Calreticulin exposure correlates with robust adaptive antitumor immunity and favorable prognosis in ovarian carcinoma patients. J Immunother Cancer. 2019;7:312.",
      "volume": "7",
      "year": "2019"
    },
    {
      "DOI": "10.1093/jjco/hyz172",
      "author": "H Ruan",
      "doi-asserted-by": "publisher",
      "first-page": "254",
      "issue": "3",
      "journal-title": "Jpn J Clin Oncol",
      "key": "372_CR29",
      "unstructured": "Ruan H, Li Y, Wang X, Sun B, Fang W, Jiang S, et al. CRYAB inhibits migration and invasion of bladder cancer cells through the PI3K/AKT and ERK pathways. Jpn J Clin Oncol. 2020;50(3):254–60.",
      "volume": "50",
      "year": "2020"
    },
    {
      "DOI": "10.1021/acs.analchem.8b00986",
      "author": "W Miao",
      "doi-asserted-by": "publisher",
      "first-page": "6835",
      "issue": "11",
      "journal-title": "Anal Chem",
      "key": "372_CR30",
      "unstructured": "Miao W, Li L, Wang Y. A targeted proteomic approach for heat shock proteins reveals DNAJB4 as a suppressor for melanoma metastasis. Anal Chem. 2018;90(11):6835–42.",
      "volume": "90",
      "year": "2018"
    },
    {
      "DOI": "10.21037/gs-20-431",
      "author": "L Mo",
      "doi-asserted-by": "publisher",
      "first-page": "1955",
      "issue": "6",
      "journal-title": "Gland Surg",
      "key": "372_CR31",
      "unstructured": "Mo L, Liu J, Yang Z, Gong X, Meng F, Zou R, et al. DNAJB4 identified as a potential breast cancer marker: evidence from bioinformatics analysis and basic experiments. Gland Surg. 2020;9(6):1955–72.",
      "volume": "9",
      "year": "2020"
    },
    {
      "DOI": "10.1038/onc.2016.106",
      "author": "C-H Chen",
      "doi-asserted-by": "publisher",
      "first-page": "5674",
      "issue": "43",
      "journal-title": "Oncogene",
      "key": "372_CR32",
      "unstructured": "Chen C-H, Chang W-H, Su K-Y, Ku W-H, Chang G-C, Hong Q-S, et al. HLJ1 is an endogenous Src inhibitor suppressing cancer progression through dual mechanisms. Oncogene. 2016;35(43):5674–85.",
      "volume": "35",
      "year": "2016"
    },
    {
      "DOI": "10.1038/s41467-019-14085-2",
      "author": "KL Marie",
      "doi-asserted-by": "publisher",
      "first-page": "333",
      "issue": "1",
      "journal-title": "Nat Commun",
      "key": "372_CR33",
      "unstructured": "Marie KL, Sassano A, Yang HH, Michalowski AM, Michael HT, Guo T, et al. Melanoblast transcriptome analysis reveals pathways promoting melanoma metastasis. Nat Commun. 2020;11(1):333.",
      "volume": "11",
      "year": "2020"
    },
    {
      "DOI": "10.1053/j.gastro.2013.12.016",
      "author": "C Vecchi",
      "doi-asserted-by": "publisher",
      "first-page": "1060",
      "issue": "4",
      "journal-title": "Gastroenterology",
      "key": "372_CR34",
      "unstructured": "Vecchi C, Montosi G, Garuti C, Corradini E, Sabelli M, Canali S, et al. Gluconeogenic signals regulate iron homeostasis via hepcidin in mice. Gastroenterology. 2014;146(4):1060-1069.e3.",
      "volume": "146",
      "year": "2014"
    },
    {
      "DOI": "10.1371/journal.pone.0032765",
      "author": "X Zhang",
      "doi-asserted-by": "publisher",
      "first-page": "e32765",
      "issue": "3",
      "journal-title": "PLoS ONE",
      "key": "372_CR35",
      "unstructured": "Zhang X, Wang X, Zhu H, Kranias EG, Tang Y, Peng T, et al. Hsp20 Functions as a novel cardiokine in promoting angiogenesis via activation of VEGFR2. Qin G, rédacteur. PLoS ONE. 2012;7(3):e32765.",
      "volume": "7",
      "year": "2012"
    },
    {
      "DOI": "10.3892/mmr.2014.2240",
      "author": "S Chen",
      "doi-asserted-by": "publisher",
      "first-page": "677",
      "issue": "2",
      "journal-title": "Mol Med Rep",
      "key": "372_CR36",
      "unstructured": "Chen S, Huang H, Yao J, Pan L, Ma H. Heat shock protein B6 potently increases non-small cell lung cancer growth. Mol Med Rep. 2014;10(2):677–82.",
      "volume": "10",
      "year": "2014"
    },
    {
      "DOI": "10.3892/or.2020.7853",
      "author": "Y Chen",
      "doi-asserted-by": "publisher",
      "first-page": "191",
      "issue": "1",
      "journal-title": "Oncol Rep",
      "key": "372_CR37",
      "unstructured": "Chen Y, Xu T, Xie F, Wang L, Liang Z, Li D, et al. Evaluating the biological functions of the prognostic genes identified by the Pathology Atlas in bladder cancer. Oncol Rep. 2021;45(1):191–201.",
      "volume": "45",
      "year": "2021"
    },
    {
      "DOI": "10.7554/eLife.29511",
      "author": "X Hong",
      "doi-asserted-by": "publisher",
      "first-page": "e29511",
      "journal-title": "Elife",
      "key": "372_CR38",
      "unstructured": "Hong X, Huang H, Qiu X, Ding Z, Feng X, Zhu Y, et al. Targeting posttranslational modifications of RIOK1 inhibits the progression of colorectal and gastric cancers. Elife. 2018;7:e29511.",
      "volume": "7",
      "year": "2018"
    },
    {
      "DOI": "10.3389/fonc.2020.553399",
      "author": "Y Wang",
      "doi-asserted-by": "publisher",
      "first-page": "553399",
      "journal-title": "Front Oncol",
      "key": "372_CR39",
      "unstructured": "Wang Y, Yan K, Lin J, Liu Y, Wang J, Li X, et al. CD8+ T cell co-expressed genes correlate with clinical phenotype and microenvironments of urothelial cancer. Front Oncol. 2020;10:553399.",
      "volume": "10",
      "year": "2020"
    },
    {
      "author": "C-T Lin",
      "first-page": "680",
      "issue": "5",
      "journal-title": "Urol Oncol Semin Orig Investig",
      "key": "372_CR40",
      "unstructured": "Lin C-T, Tung C-L, Tsai Y-S, Shen C-H, Jou Y-C, Yu M-T, et al. Prognostic relevance of preoperative circulating CD8-positive lymphocytes in the urinary bladder recurrence of urothelial carcinoma. Urol Oncol Semin Orig Investig. 2012;30(5):680–7.",
      "volume": "30",
      "year": "2012"
    },
    {
      "DOI": "10.1016/j.intimp.2019.105880",
      "author": "L Sharifi",
      "doi-asserted-by": "publisher",
      "first-page": "105880",
      "journal-title": "Int Immunopharmacol",
      "key": "372_CR41",
      "unstructured": "Sharifi L, Nowroozi MR, Amini E, Arami MK, Ayati M, Mohsenzadegan M. A review on the role of M2 macrophages in bladder cancer; pathophysiology and targeting. Int Immunopharmacol. 2019;76:105880.",
      "volume": "76",
      "year": "2019"
    },
    {
      "author": "Y Lv",
      "first-page": "7510",
      "issue": "11",
      "journal-title": "Am J Transl Res",
      "key": "372_CR42",
      "unstructured": "Lv Y, Jin P, Chen Z, Zhang P. Characterization of hazard infiltrating immune cells and relative risk genes in bladder urothelial carcinoma. Am J Transl Res. 2020;12(11):7510–27.",
      "volume": "12",
      "year": "2020"
    },
    {
      "author": "Y Xue",
      "first-page": "581",
      "issue": "2",
      "journal-title": "Oncol Rep",
      "key": "372_CR43",
      "unstructured": "Xue Y, Tong L, Liu F, Liu A, Zeng S, Xiong Q, et al. Tumor-infiltrating M2 macrophages driven by specific genomic alterations are associated with prognosis in bladder cancer. Oncol Rep. 2019;42(2):581–94.",
      "volume": "42",
      "year": "2019"
    }
  ],
  "reference-count": 43,
  "references-count": 43,
  "resource": {
    "primary": {
      "URL": "https://humgenomics.biomedcentral.com/articles/10.1186/s40246-021-00372-x"
    }
  },
  "score": 0,
  "short-container-title": [
    "Hum Genomics"
  ],
  "source": "Crossref",
  "title": [
    "Identification of a novel signature based on unfolded protein response-related gene for predicting prognosis in bladder cancer"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy",
  "volume": "15"
}